• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用转铁蛋白包被的纳米结构脂质载体将依托泊苷靶向急性髓性白血病细胞。

Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.

作者信息

Khajavinia Amir, Varshosaz Jaleh, Dehkordi Abbas Jafarian

机构信息

Faculty of Pharmacy and Novel Drug Delivery Systems Research Centre, Department of Pharmaceutics Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Nanotechnology. 2012 Oct 12;23(40):405101. doi: 10.1088/0957-4484/23/40/405101. Epub 2012 Sep 14.

DOI:10.1088/0957-4484/23/40/405101
PMID:22983592
Abstract

The aim of the present study was to evaluate the diverse properties of transferrin (Tf)-conjugated nanostructured lipid carriers (NLCs) prepared using three different fatty amines, including stearylamine (SA), dodecylamine (DA) and spermine (SP), and two different methods for Tf coupling. Etoposide-loaded NLCs were prepared by an emulsion-solvent evaporation method followed by probe sonication. Chemical coupling of NLCs with Tf was mediated by an amide linkage between the surface-exposed amino group of the fatty amine and the carboxyl group of the protein. The physical coating was performed in a Ringer-Hepes buffer medium. NLCs were characterized by their particle size, zeta potential, polydispersity index, drug entrapment percentage, drug release profiles and Tf-coupling efficiency. The cytotoxicity of NLCs on K562 acute myelogenous leukaemia cells was studied by MTT assay, and their cellular uptake was studied by a flow cytometry method. SA-containing NLCs showed the lowest particle size, the highest zeta potential and the largest coupling efficiency values. The drug entrapment percentage and the zeta potential decreased after Tf coupling, but the average particle size increased. SP-containing formulations released their drug contents comparatively slower than SA- or DA-containing NLCs. Unconjugated NLCs released moderately more drug than Tf-NLCs. Flow cytometry studies revealed enhanced cellular uptake of Tf-NLCs compared to unconjugated ones. Blocking Tf receptors resulted in a significantly higher cell survival rate for Tf-NLCs. The highest cytotoxic activity was observed in the chemically coupled SA-containing nanoparticles, with an IC(50) value of 15-fold lower than free etoposide.

摘要

本研究的目的是评估使用三种不同脂肪胺(硬脂胺(SA)、十二烷基胺(DA)和精胺(SP))制备的转铁蛋白(Tf)偶联纳米结构脂质载体(NLCs)的多种特性,以及两种不同的Tf偶联方法。通过乳化溶剂蒸发法然后探针超声处理制备载有依托泊苷的NLCs。NLCs与Tf的化学偶联是通过脂肪胺表面暴露的氨基与蛋白质的羧基之间的酰胺键介导的。物理包被在林格 - 赫佩斯缓冲介质中进行。NLCs通过其粒径、zeta电位、多分散指数、药物包封率、药物释放曲线和Tf偶联效率进行表征。通过MTT法研究NLCs对K562急性髓性白血病细胞的细胞毒性,并通过流式细胞术方法研究其细胞摄取情况。含SA的NLCs显示出最低的粒径、最高的zeta电位和最大的偶联效率值。Tf偶联后药物包封率和zeta电位降低,但平均粒径增加。含SP的制剂比含SA或DA的NLCs释放药物内容物相对较慢。未偶联的NLCs比Tf - NLCs释放的药物略多。流式细胞术研究表明,与未偶联的NLCs相比,Tf - NLCs的细胞摄取增强。阻断Tf受体导致Tf - NLCs的细胞存活率显著更高。在化学偶联的含SA纳米颗粒中观察到最高的细胞毒性活性,其IC(50)值比游离依托泊苷低15倍。

相似文献

1
Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.使用转铁蛋白包被的纳米结构脂质载体将依托泊苷靶向急性髓性白血病细胞。
Nanotechnology. 2012 Oct 12;23(40):405101. doi: 10.1088/0957-4484/23/40/405101. Epub 2012 Sep 14.
2
Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.使用Box-Behnken设计开发和优化转铁蛋白共轭纳米结构脂质载体用于紫杉醇的脑内递送
Pharm Dev Technol. 2017 May;22(3):370-382. doi: 10.1080/10837450.2016.1189933. Epub 2016 Sep 30.
3
Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.载多西紫杉醇的纳米结构脂质载体通过曲妥珠单抗(赫赛汀)靶向修饰用于 HER2 阳性乳腺癌细胞。
J Liposome Res. 2018 Dec;28(4):285-295. doi: 10.1080/08982104.2017.1370471. Epub 2017 Sep 6.
4
Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.载青蒿素靶向纳米结构脂质载体的脑递药系统:设计、制备、表征、优化及细胞毒性。
J Pharm Pharm Sci. 2018;21(1s):225s-241s. doi: 10.18433/jpps30117.
5
Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.纳米结构脂质载体作为依托泊苷口服递药载体的特性评价与评估。
Eur J Pharm Sci. 2011 Jun 14;43(3):174-9. doi: 10.1016/j.ejps.2011.04.005. Epub 2011 Apr 20.
6
Transferrin-Conjugated Nanostructured Lipid Carriers for Targeting Artemisone to Melanoma Cells.转铁蛋白偶联的纳米结构脂质载体靶向阿霉素至黑素瘤细胞。
Int J Mol Sci. 2024 Aug 22;25(16):9119. doi: 10.3390/ijms25169119.
7
A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.一种用于银屑病的新型局部制剂:载有甲氨蝶呤的纳米结构脂质载体的研发。
Int J Pharm. 2014 Dec 30;477(1-2):519-26. doi: 10.1016/j.ijpharm.2014.10.067. Epub 2014 Nov 1.
8
Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy.用于胃癌治疗的载有依托泊苷的纳米结构脂质载体。
Drug Deliv. 2016 May;23(4):1379-82. doi: 10.3109/10717544.2015.1048491. Epub 2015 Jul 10.
9
Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.转铁蛋白共轭固体脂质纳米粒用于增强盐酸奎宁向脑内的递送。
J Pharm Pharmacol. 2007 Jul;59(7):935-40. doi: 10.1211/jpp.59.7.0004.
10
Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.叶酸修饰的纳米结构脂质给药系统靶向递送至癌细胞的依托泊苷。
Drug Deliv. 2016 Jun;23(5):1838-45. doi: 10.3109/10717544.2016.1141258. Epub 2016 Feb 16.

引用本文的文献

1
Nanotechnology-assisted combination drug delivery: a progressive approach for the treatment of acute myeloid leukemia.纳米技术辅助联合药物递送:治疗急性髓系白血病的一种进展性方法。
Ther Deliv. 2024;15(11):893-910. doi: 10.1080/20415990.2024.2394012. Epub 2024 Sep 13.
2
Transferrin-Conjugated Nanostructured Lipid Carriers for Targeting Artemisone to Melanoma Cells.转铁蛋白偶联的纳米结构脂质载体靶向阿霉素至黑素瘤细胞。
Int J Mol Sci. 2024 Aug 22;25(16):9119. doi: 10.3390/ijms25169119.
3
Development and Characterization of Cationic Nanostructured Lipid Carriers as Drug Delivery Systems for miRNA-27a.
阳离子纳米结构脂质载体作为miRNA - 27a药物递送系统的开发与表征
Pharmaceuticals (Basel). 2023 Jul 14;16(7):1007. doi: 10.3390/ph16071007.
4
Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers.使用转铁蛋白修饰的纳米结构脂质载体实现雷帕霉素的脑靶向递送。
Bioimpacts. 2022;12(1):21-32. doi: 10.34172/bi.2021.23389. Epub 2021 Oct 9.
5
Lipid nanostructures for targeting brain cancer.用于靶向脑癌的脂质纳米结构
Heliyon. 2021 Sep 16;7(9):e07994. doi: 10.1016/j.heliyon.2021.e07994. eCollection 2021 Sep.
6
The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.骨髓增生异常综合征和急性髓系白血病中铁过载和铁代谢的临床意义。
Front Immunol. 2021 Feb 19;11:627662. doi: 10.3389/fimmu.2020.627662. eCollection 2020.
7
Conventional Nanosized Drug Delivery Systems for Cancer Applications.用于癌症治疗的传统纳米级药物递送系统。
Adv Exp Med Biol. 2021;1295:3-27. doi: 10.1007/978-3-030-58174-9_1.
8
Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia.纳米药物在急性髓系白血病中的靶向治疗方法
Dose Response. 2019 Dec 11;17(4):1559325819887048. doi: 10.1177/1559325819887048. eCollection 2019 Oct-Dec.
9
Nanostructured carriers as innovative tools for cancer diagnosis and therapy.纳米结构载体作为癌症诊断与治疗的创新工具。
APL Bioeng. 2019 Mar 26;3(1):011502. doi: 10.1063/1.5079943. eCollection 2019 Mar.
10
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.用于靶向脑部疾病的固体脂质纳米粒和纳米结构脂质载体的设计进展。
J Control Release. 2017 Oct 28;264:306-332. doi: 10.1016/j.jconrel.2017.08.033. Epub 2017 Aug 26.